House Bill 12 prohibits delta-8 and delta-10 sales to individuals under 21

On March 4, 2025, Maryland lawmakers introduced House Bill 12, a legislative measure aimed at regulating the sale of products containing delta-8 and delta-10 tetrahydrocannabinol (THC) to individuals under the age of 21. This bill emerges amid growing concerns about the accessibility of these cannabis-derived substances to minors, reflecting a broader national dialogue on cannabis regulation and youth safety.

The primary objective of House Bill 12 is to establish clear age restrictions on the sale of delta-8 and delta-10 THC products. Key provisions include prohibiting the sale of these products to anyone under 21 years of age, with specific defenses for sellers who verify the age of purchasers through valid identification. Additionally, the bill mandates that any website selling these products must implement an age-verification mechanism to ensure compliance with the law.

Violations of this legislation would result in misdemeanor charges, with escalating fines for repeat offenses: $300 for the first violation, $1,000 for a second violation within two years, and $3,000 for subsequent violations. This tiered penalty structure aims to deter non-compliance and reinforce the seriousness of the regulations.

The introduction of House Bill 12 has sparked discussions among lawmakers, public health advocates, and industry stakeholders. Proponents argue that the bill is a necessary step to protect youth from potential health risks associated with unregulated cannabis products. Critics, however, raise concerns about the feasibility of enforcing such regulations and the potential impact on legitimate businesses operating in the cannabis market.

The implications of this bill extend beyond immediate regulatory concerns. As states grapple with the complexities of cannabis legalization, House Bill 12 could set a precedent for how other jurisdictions approach the regulation of emerging cannabis products. Experts suggest that if passed, the bill may influence public perception of cannabis safety and contribute to a more structured framework for cannabis commerce in Maryland.

As the legislative process unfolds, stakeholders will be closely monitoring the bill's progress and potential amendments. The bill is set to take effect on July 1, 2025, should it pass through the necessary legislative hurdles. The outcome of House Bill 12 could significantly shape the landscape of cannabis regulation in Maryland, reflecting the state's commitment to balancing public health with the evolving cannabis market.